161 related articles for article (PubMed ID: 11382588)
1. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.
Samani AA; Brodt P
Surg Oncol Clin N Am; 2001 Apr; 10(2):289-312, viii. PubMed ID: 11382588
[TBL] [Abstract][Full Text] [Related]
2. The role of the plasminogen activation system in angiogenesis and metastasis.
Rabbani SA; Mazar AP
Surg Oncol Clin N Am; 2001 Apr; 10(2):393-415, x. PubMed ID: 11382594
[TBL] [Abstract][Full Text] [Related]
3. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
4. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
Zhang D; Samani AA; Brodt P
Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles in cells transformed by overexpression of the IGF-I receptor.
Loughran G; Huigsloot M; Kiely PA; Smith LM; Floyd S; Ayllon V; O'Connor R
Oncogene; 2005 Sep; 24(40):6185-93. PubMed ID: 15940254
[TBL] [Abstract][Full Text] [Related]
7. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis.
Fidler IJ
Surg Oncol Clin N Am; 2001 Apr; 10(2):257-69, vii-viiii. PubMed ID: 11382586
[TBL] [Abstract][Full Text] [Related]
8. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
9. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
10. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
Surmacz E
Oncogene; 2003 Sep; 22(42):6589-97. PubMed ID: 14528284
[TBL] [Abstract][Full Text] [Related]
11. The metastatic odyssey: the integrin connection.
Mercurio AM; Bachelder RE; Rabinovitz I; O'Connor KL; Tani T; Shaw LM
Surg Oncol Clin N Am; 2001 Apr; 10(2):313-28, viii-ix. PubMed ID: 11382589
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
Pennisi PA; Barr V; Nunez NP; Stannard B; Le Roith D
Cancer Res; 2002 Nov; 62(22):6529-37. PubMed ID: 12438247
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-I receptor as an oncogene.
Werner H; Bruchim I
Arch Physiol Biochem; 2009 May; 115(2):58-71. PubMed ID: 19485702
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumorigenicity and metastatic potential in carcinoma cells expressing the extracellular domain of the type 1 insulin-like growth factor receptor.
Samani AA; Chevet E; Fallavollita L; Galipeau J; Brodt P
Cancer Res; 2004 May; 64(10):3380-5. PubMed ID: 15150088
[TBL] [Abstract][Full Text] [Related]
15. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
16. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
Chakravarti A; Loeffler JS; Dyson NJ
Cancer Res; 2002 Jan; 62(1):200-7. PubMed ID: 11782378
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.
Mitsiades CS; Mitsiades N
Expert Rev Anticancer Ther; 2005 Jun; 5(3):487-99. PubMed ID: 16001956
[TBL] [Abstract][Full Text] [Related]
20. The biochemistry of cancer dissemination.
Price JT; Bonovich MT; Kohn EC
Crit Rev Biochem Mol Biol; 1997; 32(3):175-253. PubMed ID: 9239493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]